Israel begins human trials for Brilife vaccine
Israel has initiated human testing of the Brilife vaccine candidate, beginning with 80 volunteers. The trial will expand to 1,000 participants in December and potentially reach 30,000 in April or May.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
NewsIsrael begins human trials for Brilife vaccine
Sign in or subscribeBrowse free archive reportsIsrael has initiated human testing of the Brilife vaccine candidate, beginning with 80 volunteers. The trial will expand to 1,000 participants in December and potentially reach 30,000 in April or May.